Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
248.68
-3.32 (-1.32%)
At close: Nov 20, 2026
SHA:688506 Revenue
Sichuan Biokin Pharmaceutical had revenue of 1.91B CNY in the quarter ending September 30, 2026, with 0.63% growth. This brings the company's total for the last twelve months to 2.55B, up 14.47% year-over-year. In the year 2025, Sichuan Biokin Pharmaceutical had annual revenue of 2.52B, down -56.72%. That makes Sichuan Biokin Pharmaceutical the 12,930th largest company in the world by revenue and 2,254th in China.
Revenue (ttm)
2.55B
Revenue Growth
+14.47%
P/S Ratio
40.14
Revenue / Employee
796.78K
Employees
3,434
Market Cap
102.29B
Revenue by Geography
- Overseas 2.12B 84.8%
- China 380.08M 15.2%
Fiscal year ended Dec 31, 2025 See the full SHA:688506 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.52B | -3.30B | -56.72% |
| Dec 31, 2024 | 5.82B | 5.26B | 936.31% |
| Dec 31, 2023 | 561.87M | -141.41M | -20.11% |
| Dec 31, 2022 | 703.28M | -93.45M | -11.73% |
| Dec 31, 2021 | 796.73M | -215.98M | -21.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.97B |
| Yunnan Baiyao Group Co.,Ltd | 42.79B |
| Shanghai Fosun Pharmaceutical (Group) | 42.73B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 32.85B |
| China Resources Sanjiu Medical & Pharmaceutical | 31.03B |
| Zhejiang NHU Company | 24.84B |
| Humanwell Healthcare (Group) | 24.49B |
| Beijing Tongrentang | 15.01B |
Sichuan Biokin Pharmaceutical News
- 21 days ago - Sichuan Biokin Pharmaceutical Quarterly report: Q3 2026 - Filings
- 2 months ago - Sichuan Biokin Pharmaceutical Quarterly report: Q2 2026 - Filings